Challenges in conservative management of placenta increta with methotrexate in nulliparous woman
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20233664Keywords:
Second-trimester, Hemorrhage, Miscarriage, Placenta incretaAbstract
Placenta increta is a severe complication of pregnancy normally diagnosed during the second trimester. Early detection could reduce the risk of hemorrhage during abortion or miscarriage; however, guidelines on first‐trimester diagnosis are lacking. We describe a case of placenta increta during the second trimester with retained products of conception and its consequences followed by effective management with methotrexate.
References
Van den Bosch T, Daemen A, Van Schoubroeck D, Nathalie P, Bart DM, Dirk T. Occurrence and outcome of residual trophoblastic tissue: a prospective study. J Ultrasound Med. 2008;27(3):357-61.
Kamaya A, Petrovitch I, Chen B, Frederick CE, Jeffrey RB. Retained products of conception: spectrum of color Doppler findings. J Ultrasound Med. 2009;28(8):103141.
Jauniaux E, Ayres-de-Campos D, Langhoff RJ, Karin AF, Sally C. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146(1):20.
Jauniaux E, Chantraine F, Silver RM, Jens L-R, FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. Int J Gynaecol Obstet. 2018;140(3):265.
Jauniaux E, Hussein AM, Elbarmelgy RM, Rasha AE, Graham JB. Failure of placental detachment in accreta placentation is associated with excessive fibrinoid deposition at the utero-placental interface. Am J Obset Gynecol. 2022;226(2):243.
Jauniaux E, Hecht JL, Elbarmelgy RA, Rana ME, Mohamed MT, Ahmed MH. Searching for placenta percreta: a prospective cohort and systematic review of case reports. Am J Obstet Gynecol. 2022;226(6):837.
Jauniaux E, Jurkovic D, Hussein AM, Burton GJ. New insights into the etiopathology of placenta accreta spectrum. Am J Obstet Gynecol. 2022;227(6):384.
Jauniaux E, Fox KA, Einerson B, Ahmed MH, Jonathan LH, Robert MS. Perinatal assessment of complex cesarean delivery: beyond placenta accreta spectrum. Am J Obstet Gynecol. 2023;229(2):129.
Tantbirojn P, Crum CP, Parast MM. Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast. Placenta. 2008;29(7):639.
Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018;218(1):75.
Levine D, Hulka CA, Ludmir J. Placenta accreta: evaluation with color Doppler US, power Doppler US, and MR imaging. Radiology. 1997;205:773.
Maldjian C, Adam R, Pelosi M. MRI appearance of placenta percreta and placenta accreta. Magn Reson Imaging. 1999;17(7):965.
Kirkinen P, Helin-Martikainen HL, Vanninen R, Partanen K. Placenta accreta: imaging by gray-scale and contrast-enhanced color Doppler sonography and magnetic resonance imaging. J Clin Ultrasound. 1998;26(2):90.
De Oliveira Carniello M, Oliveira Brito LG, Sarian LO, Bennini JR. Diagnosis of placenta accreta spectrum in high-risk women using ultrasonography or magnetic resonance imaging: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022;59(4):428.
